1.0
Apr 12, 2024
Former employee, more than 10 years
Recommend
CEO approval
Business Outlook
Pros
Has good 401K match and financial resources.
Cons
Lost sincere patient-centricity (of Genzyme) with Sanofi’s hostile takeover. Poor future vision led to reactive and frequent project changes and layoffs. Heartless implementation of COVID-19 vaccine mandate.